<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2010-606</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-291</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Актовегин в комплексной терапиисосудистых нарушений при антифосфолипидном синдроме</article-title><trans-title-group xml:lang="en"><trans-title>ACTOVEGIN IN THE COMPLEX THERAPY OF VASCULAR DISORDERS IN ANTIPHOSPHOLIPID SYNDROME</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Середавкина</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Seredavkina</surname><given-names>N V</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буренчев</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Burenchev</surname><given-names>D V</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Решетняк</surname><given-names>Т. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Reshetnyak</surname><given-names>T M</given-names></name></name-alternatives><email xlink:type="simple">t_reshetnyak@yahoo.com &amp;lt;mailto:t_reshetnyak@yahoo.com&amp;gt;</email></contrib></contrib-group><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2010</year></pub-date><volume>4</volume><issue>2</issue><issue-title>№2 (2010)</issue-title><fpage>66</fpage><lpage>73</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Середавкина Н.В., Буренчев Д.В., Решетняк Т.М., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Середавкина Н.В., Буренчев Д.В., Решетняк Т.М.</copyright-holder><copyright-holder xml:lang="en">Seredavkina N.V., Burenchev D.V., Reshetnyak T.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/291">https://mrj.ima-press.net/mrj/article/view/291</self-uri><abstract><p>Антифосфолипидный синдром (АФС) - заболевание, характеризующееся рецидивирующими артериальными и/или венозными тромбозами, тромбоцитопенией и акушерской патологией при наличии антифосфолипидных антител. Клинические проявления АФС очень разнообразны и напрямую зависят от локализации тромбоза. В статье обсуждается необходимость проведения комплексной патогенетической и симптоматической терапии АФС, приводится теоретическое обоснование применения препарата Актовегин. Авторы представляют собственный клинический опыт терапии сосудистых нарушений при АФС</p></abstract><trans-abstract xml:lang="en"><p>Antifosfolipidnyy sindrom (AFS) - zabolevanie, kharakterizuyushcheesya retsidiviruyushchimi arterial'nymi i/ili venoznymi trombozami, trombotsitopeniey i akusherskoy patologiey pri nalichii antifosfolipidnykh antitel. Klinicheskie proyavleniya AFS ochen' raznoobrazny i napryamuyu zavisyat ot lokalizatsii tromboza. V stat'e obsuzhdaetsya neobkhodimost' provedeniya kompleksnoy patogeneticheskoy i simptomaticheskoy terapii AFS, privoditsya teoreticheskoe obosnovanie primeneniya preparata Aktovegin. Avtory predstavlyayut sobstvennyy klinicheskiy opyt terapii sosudistykh narusheniy pri AFS</p></trans-abstract><kwd-group xml:lang="ru"><kwd>антифосфолипидный синдром</kwd><kwd>сосудистые нарушения</kwd><kwd>тромбоз</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
